Journal articles on the topic 'HIV-1 proteasi'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'HIV-1 proteasi.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Pan, Bowen, Sumei Li, Junwei Xiao, Xin Yang, Shouxia Xie, Ying Zhou, Jian Yang, and Ying Wei. "Dual Inhibition of HIV-1 and Cathepsin L Proteases by Sarcandra glabra." Molecules 27, no. 17 (August 29, 2022): 5552. http://dx.doi.org/10.3390/molecules27175552.
Full textPark, Jung-Ho, Yoshihiro Yamaguchi, and Masayori Inouye. "Intramolecular Regulation of the Sequence-Specific mRNA Interferase Activity of MazF Fused to a MazE Fragment with a Linker Cleavable by Specific Proteases." Applied and Environmental Microbiology 78, no. 11 (March 23, 2012): 3794–99. http://dx.doi.org/10.1128/aem.00364-12.
Full textCapel, Elena, Glòria Martrus, Mariona Parera, Bonaventura Clotet, and Miguel Angel Martínez. "Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness." Journal of General Virology 93, no. 12 (December 1, 2012): 2625–34. http://dx.doi.org/10.1099/vir.0.045492-0.
Full textMartínez, Miguel-Angel, Marta Cabana, Mariona Parera, Arantxa Gutierrez, José A. Esté, and Bonaventura Clotet. "A Bacteriophage Lambda-Based Genetic Screen for Characterization of the Activity and Phenotype of the Human Immunodeficiency Virus Type 1 Protease." Antimicrobial Agents and Chemotherapy 44, no. 5 (May 1, 2000): 1132–39. http://dx.doi.org/10.1128/aac.44.5.1132-1139.2000.
Full textMcPHEE, Fiona, Patricia S. CALDERA, Guy W. BEMIS, Antony F. McDONAGH, Irwin D. KUNTZ, and Charles S. CRAIK. "Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro." Biochemical Journal 320, no. 2 (December 1, 1996): 681–86. http://dx.doi.org/10.1042/bj3200681.
Full textRaugi, Dana N., Robert A. Smith, and Geoffrey S. Gottlieb. "Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease Inhibitors." Journal of Virology 90, no. 2 (November 11, 2015): 1062–69. http://dx.doi.org/10.1128/jvi.01772-15.
Full textÁlvarez, Enrique, Luis Menéndez-Arias, and Luis Carrasco. "The Eukaryotic Translation Initiation Factor 4GI Is Cleaved by Different Retroviral Proteases." Journal of Virology 77, no. 23 (December 1, 2003): 12392–400. http://dx.doi.org/10.1128/jvi.77.23.12392-12400.2003.
Full textÁlvarez, Enrique, Alfredo Castelló, Luis Menéndez-Arias, and Luis Carrasco. "HIV protease cleaves poly(A)-binding protein." Biochemical Journal 396, no. 2 (May 15, 2006): 219–26. http://dx.doi.org/10.1042/bj20060108.
Full textDAVIS, David A., Fonda M. NEWCOMB, Jackob MOSKOVITZ, Paul T. WINGFIELD, Stephen J. STAHL, Joshua KAUFMAN, Henry M. FALES, Rodney L. LEVINE, and Robert YARCHOAN. "HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase." Biochemical Journal 346, no. 2 (February 22, 2000): 305–11. http://dx.doi.org/10.1042/bj3460305.
Full textSohraby, Farzin, and Hassan Aryapour. "Comparative analysis of the unbinding pathways of antiviral drug Indinavir from HIV and HTLV1 proteases by supervised molecular dynamics simulation." PLOS ONE 16, no. 9 (September 27, 2021): e0257916. http://dx.doi.org/10.1371/journal.pone.0257916.
Full textSavarino, Andrea, Roberto Cauda, and Antonio Cassone. "Aspartic Proteases ofPlasmodium falciparumas the Target of HIV‐1 Protease Inhibitors." Journal of Infectious Diseases 191, no. 8 (April 15, 2005): 1381–82. http://dx.doi.org/10.1086/428781.
Full textVisnegarwala, Fehmida, Daniel M. Musher, and A. C. White. "HIV-1 Protease Inhibitors May Interfere with the Ubiquitous Intracellular Proteases." Annals of Internal Medicine 135, no. 9 (November 6, 2001): 840. http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00017.
Full textYanchunas, Joseph, David R. Langley, Li Tao, Ronald E. Rose, Jacques Friborg, Richard J. Colonno, and Michael L. Doyle. "Molecular Basis for Increased Susceptibility of Isolates with Atazanavir Resistance-Conferring Substitution I50L to Other Protease Inhibitors." Antimicrobial Agents and Chemotherapy 49, no. 9 (September 2005): 3825–32. http://dx.doi.org/10.1128/aac.49.9.3825-3832.2005.
Full textEron, Joseph J. "HIV-1 Protease Inhibitors." Clinical Infectious Diseases 30, Supplement_2 (June 1, 2000): S160—S170. http://dx.doi.org/10.1086/313853.
Full text&NA;. "HIV-1 protease inhibitors." Inpharma Weekly &NA;, no. 840 (June 1992): 13. http://dx.doi.org/10.2165/00128413-199208400-00018.
Full textEdwards, Paul. "HIV-1 protease inhibitors." Drug Discovery Today 6, no. 8 (April 2001): 437–39. http://dx.doi.org/10.1016/s1359-6446(01)01736-6.
Full textDeeks, Steven G. "HIV-1 Protease Inhibitors." JAMA 277, no. 2 (January 8, 1997): 145. http://dx.doi.org/10.1001/jama.1997.03540260059037.
Full textParikh, Sunil, Jiri Gut, Eva Istvan, Daniel E. Goldberg, Diane V. Havlir, and Philip J. Rosenthal. "Antimalarial Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors." Antimicrobial Agents and Chemotherapy 49, no. 7 (July 2005): 2983–85. http://dx.doi.org/10.1128/aac.49.7.2983-2985.2005.
Full textBagossi, Péter, Tamás Sperka, Anita Fehér, János Kádas, Gábor Zahuczky, Gabriella Miklóssy, Péter Boross, and József Tözsér. "Amino Acid Preferences for a Critical Substrate Binding Subsite of Retroviral Proteases in Type 1 Cleavage Sites." Journal of Virology 79, no. 7 (April 1, 2005): 4213–18. http://dx.doi.org/10.1128/jvi.79.7.4213-4218.2005.
Full textLin, Ying-Chuan, Zachary Beck, Taekyu Lee, Van-Duc Le, Garrett M. Morris, Arthur J. Olson, Chi-Huey Wong, and John H. Elder. "Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease." Journal of Virology 74, no. 10 (May 15, 2000): 4710–20. http://dx.doi.org/10.1128/jvi.74.10.4710-4720.2000.
Full textASANTE-APPIAH, Ernest, and William W. C. CHAN. "Synergistic binding of inhibitors to the protease from HIV type 1." Biochemical Journal 315, no. 1 (April 1, 1996): 113–17. http://dx.doi.org/10.1042/bj3150113.
Full textPettit, Steven C., Sergei Gulnik, Lori Everitt, and Andrew H. Kaplan. "The Dimer Interfaces of Protease and Extra-Protease Domains Influence the Activation of Protease and the Specificity of GagPol Cleavage." Journal of Virology 77, no. 1 (January 1, 2003): 366–74. http://dx.doi.org/10.1128/jvi.77.1.366-374.2003.
Full textDavis, David A., Haydar Bulut, Prabha Shrestha, Hiroaki Mitsuya, and Robert Yarchoan. "Regulation of Retroviral and SARS-CoV-2 Protease Dimerization and Activity through Reversible Oxidation." Antioxidants 11, no. 10 (October 18, 2022): 2054. http://dx.doi.org/10.3390/antiox11102054.
Full textDekhtyar, Tatyana, Teresa I. Ng, Liangjun Lu, Sherie Masse, David A. DeGoey, William J. Flosi, David J. Grampovnik, Larry L. Klein, Dale J. Kempf, and Akhteruzzaman Molla. "Characterization of a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, A-790742." Antimicrobial Agents and Chemotherapy 52, no. 4 (January 22, 2008): 1337–44. http://dx.doi.org/10.1128/aac.01132-07.
Full textMeek, Thomas D. "Inhibitors of HIV-1 Protease." Journal of Enzyme Inhibition 6, no. 1 (January 1992): 65–98. http://dx.doi.org/10.3109/14756369209041357.
Full textPapa, Anna, Evagelia Papadimitriou, Androniki Papoutsi, and Antonis Antoniadis. "M36I, protease gene, HIV-1." AIDS 17, no. 12 (August 2003): 1858–59. http://dx.doi.org/10.1097/00002030-200308150-00019.
Full textBaures, Paul W. "Heterocyclic HIV-1 Protease Inhibitors." Organic Letters 1, no. 2 (July 1999): 249–52. http://dx.doi.org/10.1021/ol990586y.
Full textLouis, John M., Rieko Ishima, Issa Nesheiwat, Lewis K. Pannell, Shannon M. Lynch, Dennis A. Torchia, and Angela M. Gronenborn. "Revisiting Monomeric HIV-1 Protease." Journal of Biological Chemistry 278, no. 8 (December 4, 2002): 6085–92. http://dx.doi.org/10.1074/jbc.m209726200.
Full textIkezoe, Takayuki, Yasuko Hisatake, Tamotsu Takeuchi, Yuji Ohtsuki, Yang Yang, Jonathan W. Said, Hirokuni Taguchi, and H. Phillip Koeffler. "HIV-1 Protease Inhibitor, Ritonavir." Cancer Research 64, no. 20 (October 15, 2004): 7426–31. http://dx.doi.org/10.1158/0008-5472.can-03-2677.
Full textBonini, Carlo, Lucia Chiummiento, Margherita De Bonis, Nadia Di Blasio, Maria Funicello, Paolo Lupattelli, Rocco Pandolfo, Francesco Tramutola, and Federico Berti. "Synthesis of New Thienyl Ring Containing HIV-1 Protease Inhibitors: Promising Preliminary Pharmacological Evaluation against Recombinant HIV-1 Proteases§." Journal of Medicinal Chemistry 53, no. 4 (February 25, 2010): 1451–57. http://dx.doi.org/10.1021/jm900846f.
Full textPrabu-Jeyabalan, Moses, Ellen A. Nalivaika, Nancy M. King, and Celia A. Schiffer. "Structural Basis for Coevolution of a Human Immunodeficiency Virus Type 1 Nucleocapsid-p1 Cleavage Site with a V82A Drug-Resistant Mutation in Viral Protease." Journal of Virology 78, no. 22 (November 15, 2004): 12446–54. http://dx.doi.org/10.1128/jvi.78.22.12446-12454.2004.
Full textKádas, János, Péter Boross, Irene T. Weber, Péter Bagossi, Krisztina Matúz, and József Tözsér. "C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity." Biochemical Journal 416, no. 3 (November 26, 2008): 357–64. http://dx.doi.org/10.1042/bj20071132.
Full textPan, Bo Wen, Jun Wei Xiao, Su Mei Li, Xin Yang, Xia Zhou, Qing Wen Sun, Mei Chen, et al. "Inhibitors of HIV-1 and Cathepsin L Proteases Identified from the Insect Gall of Hypericum kouytchense." Pharmaceuticals 15, no. 12 (November 30, 2022): 1499. http://dx.doi.org/10.3390/ph15121499.
Full textWlodawer, A., M. Miller, M. Jaskolski, B. Sathyanarayana, E. Baldwin, I. Weber, L. Selk, L. Clawson, J. Schneider, and S. Kent. "Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease." Science 245, no. 4918 (August 2, 1989): 616–21. http://dx.doi.org/10.1126/science.2548279.
Full textBossi, Philippe, Mireille Mouroux, Anne Yvon, François Bricaire, Henri Agut, Jean-Marie Huraux, Christine Katlama, and Vincent Calvez. "Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor." Journal of Clinical Microbiology 37, no. 9 (1999): 2910–12. http://dx.doi.org/10.1128/jcm.37.9.2910-2912.1999.
Full textHu, Qing-Xiu, Guo-Qing Zhang, Rui-Ying Zhang, Dan-Dan Hu, He-Xiang Wang, and Tzi Bun Ng. "A Novel Aspartic Protease with HIV-1 Reverse Transcriptase Inhibitory Activity from Fresh Fruiting Bodies of the Wild MushroomXylaria hypoxylon." Journal of Biomedicine and Biotechnology 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/728975.
Full textMammano, Fabrizio, Caroline Petit, and François Clavel. "Resistance-Associated Loss of Viral Fitness in Human Immunodeficiency Virus Type 1: Phenotypic Analysis of Protease andgag Coevolution in Protease Inhibitor-Treated Patients." Journal of Virology 72, no. 9 (September 1, 1998): 7632–37. http://dx.doi.org/10.1128/jvi.72.9.7632-7637.1998.
Full textCordelier, Pierre, and David S. Strayer. "Mechanisms of α1-antitrypsin inhibition of cellular serine proteases and HIV-1 protease that are essential for HIV-1 morphogenesis." Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1638, no. 3 (July 2003): 197–207. http://dx.doi.org/10.1016/s0925-4439(03)00084-x.
Full textRhee, Soo-Yon, Jonathan Taylor, W. Jeffrey Fessel, David Kaufman, William Towner, Paolo Troia, Peter Ruane, et al. "HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance." Antimicrobial Agents and Chemotherapy 54, no. 10 (July 26, 2010): 4253–61. http://dx.doi.org/10.1128/aac.00574-10.
Full textHernandez-Sanchez, Pedro G., Sandra E. Guerra-Palomares, J. Rafael Arguello, Daniel E. Noyola, and Christian A. Garcia-Sepulveda. "Mexican HIV-1 Protease Sequence Diversity." AIDS Research and Human Retroviruses 36, no. 2 (February 1, 2020): 161–66. http://dx.doi.org/10.1089/aid.2019.0201.
Full textBeck, Z., G. Morris, and J. Elder. "Defining HIV-1 Protease Substrate Selectivity." Current Drug Target -Infectious Disorders 2, no. 1 (March 1, 2002): 37–50. http://dx.doi.org/10.2174/1568005024605837.
Full textIshima, Rieko, Rodolfo Ghirlando, József Tözsér, Angela M. Gronenborn, Dennis A. Torchia, and John M. Louis. "Folded Monomer of HIV-1 Protease." Journal of Biological Chemistry 276, no. 52 (October 11, 2001): 49110–16. http://dx.doi.org/10.1074/jbc.m108136200.
Full textCatamancio, Simona La Seta, and Stefano Rusconi. "HIV-1 protease inhibitors in development." Expert Opinion on Investigational Drugs 11, no. 3 (March 2002): 387–95. http://dx.doi.org/10.1517/13543784.11.3.387.
Full textMargolin, Nara, Albert Dee, Mei Lai, and Chris J. Vlahos. "Purification of Recombinant HIV-1 Protease." Preparative Biochemistry 21, no. 2-3 (June 1991): 163–73. http://dx.doi.org/10.1080/10826069108018011.
Full textHeal, J. W., S. A. Wells, E. Jimenez-Roldan, R. F. Freedman, and R. A. Römer. "Rigidity analysis of HIV-1 protease." Journal of Physics: Conference Series 286 (March 1, 2011): 012006. http://dx.doi.org/10.1088/1742-6596/286/1/012006.
Full textVacca, J. P., P. M. D. Fitzgerald, M. K. Holloway, R. W. Hungate, K. E. Starbuck, L. J. Chen, P. L. Darke, P. S. Anderson, and J. R. Huff. "Conformationally constrained HIV-1 protease inhibitors." Bioorganic & Medicinal Chemistry Letters 4, no. 3 (February 1994): 499–504. http://dx.doi.org/10.1016/0960-894x(94)80025-1.
Full textVacca, Joseph P., and Jon H. Condra. "Clinically effective HIV-1 protease inhibitors." Drug Discovery Today 2, no. 7 (July 1997): 261–72. http://dx.doi.org/10.1016/s1359-6446(97)01053-2.
Full textBlanco, Raquel, Luis Carrasco, and Iván Ventoso. "Cell Killing by HIV-1 Protease." Journal of Biological Chemistry 278, no. 2 (October 4, 2002): 1086–93. http://dx.doi.org/10.1074/jbc.m205636200.
Full textRozzelle, James E., Deborah S. Dauber, Stephen Todd, Robert Kelley, and Charles S. Craik. "Macromolecular Inhibitors of HIV-1 Protease." Journal of Biological Chemistry 275, no. 10 (March 10, 2000): 7080–86. http://dx.doi.org/10.1074/jbc.275.10.7080.
Full textYao, Shao, Reena Zutshi, and Jean Chmielewski. "Endothiopeptide inhibitors of HIV-1 protease." Bioorganic & Medicinal Chemistry Letters 8, no. 6 (March 1998): 699–704. http://dx.doi.org/10.1016/s0960-894x(98)00100-0.
Full text